New combo aims to improve leukemia treatment
NCT ID NCT06773936
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 17 times
Summary
This study tests whether adding the drug asciminib to usual treatment works better for people newly diagnosed with a specific type of leukemia (Ph+ ALL). About 55 adults will receive a combination of asciminib, dasatinib, prednisone, and blinatumomab. The main goal is to see if this approach leads to a deeper remission of the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baptist Memorial Health Care
Memphis, Tennessee, 38120, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Northwell Health/Center for Advanced Medicine
Lake Success, New York, 11042, United States
-
UC Irvine Medical Center
Orange, California, 92868, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
University of Cincinnati Cancer Ctr-UC Medical Ctr
Cincinnati, Ohio, 45267, United States
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.